Liaoning Hospital of Traditional Chinese Medicine   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Liaoning China (1958)

Organization Overview

First Clinical Trial
2006
NCT00965471
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of Liaoning University of TCM | Affiliated Hospital of Liaoning University of Traditional Chinese Medicine | Liaoning Hospital of TCM | Liaoning Hospital of Traditional Chinese Medicine | Liaoning University of Traditional Chinese Medicine | Long Island Jewish Hospital (LIJ) | The Affiliated Hospital of Liaoning Hospital of Traditional Chinese Medicine | The Affiliated Hospital of Liaoning University of TCM | The affiliated hospital of Liaoning University of Traditional Chinese Medicine | the first affiliated hospital of Liaoning university of traditional Chinese medicine

Active Ingredients

Drugs in Phase 4 Trials (19)

acetylsalicylic acid (aspirin) (1 trial)

atorvastatin (lipitor) (1 trial)

chenxiang (1 trial)

chixiangshen tongxin (1 trial)

chuanxiong (1 trial)

clopidogrel (plavix) (1 trial)

danzhen (1 trial)

deng zhan sheng mai (1 trial)

fufangshuanghua (1 trial)

gualou (1 trial)

guanxin shutong (1 trial)

jinyebaidu (1 trial)

louxiangdan tongxin (1 trial)

nitroglycerin (transderm-nitro) (2 trials)

pinellia (3 trials)

taoren (1 trial)

xiebai (1 trial)

xingnaojing (1 trial)

zhiqiao (1 trial)

Drugs in Phase 3 Trials (11)

5lgr (1 trial)

losartan (cozaar) (2 trials)

mecobalamin (1 trial)

ondansetron (zofran) (1 trial)

qianyangyuyin (1 trial)

qi-zheng-xiao-tong (1 trial)

tang-min ling (1 trial)

tiaprizal (1 trial)

tong-luo-qu-tong (1 trial)

xuefu zhuyu (1 trial)

yiqi huoxue huatan (1 trial)

Drugs in Phase 2 Trials (3)

budesonide (rhinocort) (1 trial)

theophylline (synophylate) (1 trial)

ziying (1 trial)

Drugs in Phase 1 Trials (4)

buprenorphine (1 trial)

jianpi qinghua (1 trial)

mudan (1 trial)

tangbi (1 trial)

Drugs in Other Trials (29)

albuterol (proventil) (1 trial)

astragalus membranaceus (1 trial)

azimtamide (1 trial)

azithromycin (zithromax) (1 trial)

captopril (capoten) (1 trial)

corticotropin (acthar) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

erythromycin (ilosone) (1 trial)

feng re bi fei zheng (1 trial)

fuxiong san (2 trials)

ginseng (1 trial)

guaifenesin (1 trial)

hua tan san (1 trial)

ibuprofen (motrin) (1 trial)

oseltamivir (tamiflu) (1 trial)

qi ji shen kang (1 trial)

radix curcumae (1 trial)

radix scutellariae (1 trial)

rhizoma atractylodis (1 trial)

rhizoma coptidis (1 trial)

rhizoma zingiberis (1 trial)

ribavirin (virazole) (1 trial)

roasted bighead atractylodes rhizome (1 trial)

simethicone (IMODIUM) (1 trial)

spreading hedyotis herb (1 trial)

tripterygium wilfordii (1 trial)

xiaoer qingfei heji (1 trial)

xiyanping (3 trials)

zhi ke san (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Asthma (Phase 2)

Cerebral Infarction (Phase 4)

Chronic Pain (Phase 1)

Communicable Diseases (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Disease (Phase 3)

Gastritis (Phase 3)

Gastroenteritis (Phase 3)

Gastroesophageal Reflux (Phase 1)

Heart Diseases (Phase 4)

Hypertension (Phase 3)

IgA Vasculitis (Phase 2)

Infections (Phase 4)

Ischemia (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Musculoskeletal Diseases (Phase 3)

Myocardial Ischemia (Phase 4)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Polyneuropathies (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Purpura (Phase 2)

Respiratory Insufficiency (Phase 3)

Respiratory Tract Infections (Phase 4)

Stroke (Phase 4)

Tic Disorders (Phase 3)

Tics (Phase 3)

Tourette Syndrome (Phase 3)

Vomiting (Phase 3)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 24
  • # of Trial APIs: 66